Mon, Nov 24, 2014, 4:45 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Omeros Corporation (OMER) Message Board

  • rrtzrealmd rrtzrealmd Jul 28, 2014 11:02 AM Flag

    Speaking of clinical trials...

    I noticed on the clinicaltrials website gOMER's:

    "A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement"

    Sixty patients? Won't be completed for THREE MORE YEARS? Then I just glanced around to see how many child cataract surgeries are actually done. I found one retrospective study entitled "Glaucoma following cataract surgery in children: surgically modifiable risk factors." The authors rounded up ALL of the cataract surgery done on children between 1995 and 2001. They found that surgeries were done on a TOTAL of 116 eyes from 79 children. Let's years is 84 months, so we're talking about maybe one and a half (ewwwwww!) eyeballs every month?

    Doesn't seem like a real intelligent way to spend shareholders money, does it? I mean, so far gOMER hasn't even demonstrated a market for the stuff in adults, so why pour money into a trial where the patient population is near nil? Although I guess it does make a good "talking point" for the next secondary, right? You know, saving all the little childrens' eyeballs and all that...HAW!

20.74+0.62(+3.08%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.